StemCells will shut down By: MarketMinute.com Stock News May 31, 2016 at 16:48 PM EDT StemCells Inc. (Nasdaq: STEM) terminated a mid-stage clinical trial and will wind down the company. The stock price plummeted $2.46 to close at $0.57.